Arrowgrass Capital Partners (US)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-102,200
| Closed | -$8.63M | – | 165 |
|
|
2019
Q2 | $8.63M | Buy |
+102,200
| New | +$8.63M | 0.2% | 94 |
|
|
2018
Q2 | – | Sell |
-84,002
| Closed | -$6.97M | – | 171 |
|
|
2018
Q1 | $6.97M | Buy |
84,002
+9,702
| +13% | +$805K | 0.24% | 57 |
|
|
2017
Q4 | $5.77M | Buy |
+74,300
| New | +$5.77M | 0.06% | 110 |
|
|
2015
Q2 | – | Sell |
-40,000
| Closed | -$1.59M | – | 302 |
|
|
2015
Q1 | $1.59M | Buy |
+40,000
| New | +$1.59M | 0.02% | 153 |
|